Can the remuneration scheme of general practitioners affect their antibiotic prescription behaviour?
Yana V. Zykova, Eivor H. Hoff, Kristian B. Kraft, Arnstein Mykletun, Kristian A. Østby

TL;DR
This study finds that general practitioners' payment methods influence their antibiotic prescription rates, with fee-for-service and capitation models linked to higher use.
Contribution
The study is the first to analyze how GP remuneration schemes affect antibiotic prescribing for respiratory infections using Norwegian registry data.
Findings
FFS/CAP GPs had a 12–15% higher probability of prescribing antibiotics for RTIs than salaried GPs.
FFS/CAP GPs were 9–11% more likely to choose non-phenoxymethylpenicillin antibiotics.
Switching to FFS/CAP increased prescription rates by 14% and non-PcV choice by 8% among regular GPs.
Abstract
Antibiotic resistance poses a significant global health threat, exacerbated by over-prescription of antibiotics, which often happens in primary care for respiratory tract infections (RTIs). Studies indicate that up to half of these prescriptions may be unnecessary. Little is known about how general practitioners’ (GPs) remuneration schemes influence prescribing. GPs compensated via fee-for-service (FFS) and capitation (CAP) may face stronger incentives to prescribe antibiotics compared to salaried GPs, as prescriptions can signal quality, reduce consultation time, and aid patient retention — critical where reimbursements depend on consultations and list size. This study examines how GP remuneration influences antibiotic prescribing for RTIs using Norwegian register data. We utilized linked registry data (2015–2019) from the Control and Payment of Health Reimbursements Database (KUHR),…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Use and Resistance · Medication Adherence and Compliance · Pharmaceutical Economics and Policy
